Annual Drug Patent Expirations for EVAMIST
Evamist is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
Drug patent litigation for EVAMIST.
This drug has seventeen patent family members in ten countries.
The generic ingredient in EVAMIST is estradiol. One supplier is listed for this compound. Additional details are available on the estradiol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
